Document is current
Any future updates will be listed below
-
Authors
Singi, Siddharth https://orcid.org/0009-0005-6184-5239
Sun, Shenghuan https://orcid.org/0000-0002-4339-2716
Yin, Zhanghan
Gupta, Riya
Webb, Dylan C.
Bilal, Khawaja H.
Dilip, Deepika
Wang, Linlin
Kumar, Neeraj
Nanda, Swaraj
Sanchez, Nicolas
Cleave, Jacob G. Van
Fried, Brenda https://orcid.org/0000-0001-5972-6146
Paulsen, Sean https://orcid.org/0000-0002-6625-2863
Yan, Ethan S. https://orcid.org/0009-0005-6332-6803
Kamali, Ali
Sarkar, Argho
Manzo, Allyne https://orcid.org/0009-0004-3056-1180
Baik, Jeeyeon
Isgor, Irem S.
Colorado-Jimenez, Cesar
Cardillo, Anthony
Boiocchi, Leonardo
Syed, Aijazuddin
Kim, David https://orcid.org/0000-0002-7593-6052
Kezlarian-Sachs, Brie
Fenelus, Maly https://orcid.org/0000-0003-1959-4489
Chan, Alexander https://orcid.org/0000-0001-5884-8424
Yabe, Mariko
McCash, Samuel I. https://orcid.org/0000-0003-2028-4058
Zhu, Menglei
Mantha, Simon https://orcid.org/0000-0003-4277-5261
Ardon, Orly https://orcid.org/0000-0001-8147-933X
McVoy, Lauren
Xiao, Wenbin https://orcid.org/0000-0001-8586-8500
Roshal, Mikhail
Lin, Oscar
Dogan, Ahmet https://orcid.org/0000-0001-6576-5256
Carmichael, Iain
Vanderbilt, Chad https://orcid.org/0000-0002-8114-0237
Goldgof, Gregory M. https://orcid.org/0000-0001-8732-9834
-
Funding
Funding for this research was provided by:
Memorial Sloan-Kettering Cancer Center
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 13 March 2026
First Online: 15 April 2026
Competing interests
: L.B. reports stock ownership in Exact Sciences. M.Y. reports consulting for Janssen Research and Development. S.M. reports equity interest in Daboia Consulting LLC and professional services for Janssen Pharmaceuticals, Medical Case Management Group, North American Thrombosis Forum, and Physicians’ Education Resource. W.X. reports research support from Stemline Therapeutics. M.R. reports serving as a scientific advisory board member with equity support at Auron Pharmaceutical, research funding from Celularity, Roche-Genentech, Beat AML, and NGM, and travel funding from BD Biosciences. O.L. reports consulting fees from Janssen Biotech and Hologic, and support for professional activities from the American Society of Cytopathology. A.D. reports consulting for Seattle Genetics, Takeda, EUSA Pharma, AbbVie, Peerview, Physicians’ Education Resource, Incyte, and Loxo, as well as research support from Roche and Takeda. C.V. reports equity interest and intellectual property rights in Paige.AI, Inc., and a consulting and advisory role for Paige.AI, Inc. G.M.G. reports equity interest in HemeAI, Inc. The following authors declare no competing interests: Si.S., Sh.S., Z.Y., R.G., D.W., K.B., D.D., L.W., N.K., S.N., N.S., J.C., B.F., S.P., E.Y., A.K., Ar.S., A.M., J.B., I.I., C.C.J., Al.C., Ai.S., D.K., B.K., M.F., An.C., S.M., M.Z., O.A., La.M., and I.C.
